PATENT CLAIM ANALYSIS

Application Number: 16000108
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "412000"]

Abstract:
The present invention provides compounds that modulate protein function, specifically phosphodiesterase 4 (PDE4). The invention provides methods of treating, ameliorating, and/or preventing diseases, disorders, and conditions associated with PDE4. Compositions, including in combination with other inflammatory mediators, are also provided.

Claim (Index 17):
The compound of  claim 1 , wherein R 4  and R 5 , together with the atoms to which they are attached, form an optionally substituted 5 or 6 membered heterocyclyl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12657801', '13830486', '14574007', '14552226', '13830712']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8041902253635268
- 35 USC 102 Novelty (BERT): 0.516561633958896
- Combined Prediction Score: 0.7754273662230637
- Mean Citation Score: 306.77598
- Max Citation Score: 310.447
- Similarity Product: 233.83813429892064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test